ASCO 2026 - with Dr. Katarzyna Jerzak: HER2+ MBC Update: DB-09, HER2CLIMB-05 and recent ESMO guidelines

Dr. Katarzyna Jerzak reviews key ASCO 2026 updates in HER2-positive metastatic breast cancer, including DB-09, HER2CLIMB-05, evolving maintenance strategies, and their implications for recent ESMO guidelines and upcoming REAL Alliance recommendations.